| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 2-4 週間 |
| 被験者数 | 24 |
| 性別 | 男女 |
| 年齢 | 30-44 |
| 体型 | 平均 |
この研究の注釈：
21 days supplementation of colostrum in persons with HIV/AIDS associated diarrhea (no placebo control) noted significant reductions in stool weight and frequency associated with powdered colostrum () but not encapsulated colostrum (), with the reduction seen with powdered colostrum being from 6.6 defecations daily down to 5.4.
21 days supplementation of colostrum in persons with HIV/AIDS associated diarrhea (no placebo control) noted significant reductions in stool weight and frequency associated with powdered colostrum () but not encapsulated colostrum (), with the reduction seen with powdered colostrum being from 6.6 defecations daily down to 5.4.
Patients not infected by Cryptosporidium parvum did not experience benefit from powdered colostrum.